TORONTO--(BUSINESS WIRE)--$HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today,
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced that the World Intellectual Property Organization (WIPO)
Governor Kemp Joins Kubota and Company Leaders at Event in Support of Aggressive Growth Strategy and Adding More Georgia Jobs GAINESVILLE, Ga.--(BUSINESS WIRE)--Kubota North America Corporation (KNA), the parent company for Kubota Tractor Corporation (KT
CHAPEL HILL, N.C. & TORONTO & LONDON--(BUSINESS WIRE)--AESARA is pleased to announce the return of Chad Patel to the AESARA team (www.aesara.com). "Chad represents a new breed of Life Sciences industry executives with extensive field experience coupled wi
Flora’s JustCBD brand will launch sales of its premium CBD products in airports across the US, distributed by distribution company OTG Management Initial airports to distribute JustCBD include Houston’s George Bush Intercontinental/Houston Airport
TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Daikichiro Kobayashi, hereinafter “Meiji”) today announced that the first patient was dosed in Phase II clinical trial of ME3183, a selec
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd (TSX and NYSE: NTR) announced today plans to release first quarter earnings results on Monday, May 2, 2022, after market close. Nutrien will host a conference call the following day, Tuesday, May 3, 20
TORONTO--(BUSINESS WIRE)--$HUGE #FSDPharma--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today
The Fertility Partners offers clinics the support to scale their business, improve patient experiences and outcomes, with a business model and value set that aligns with leading fertility clinics’ goals for growth TORONTO--(BUSINESS WIRE)--The Fertilit
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™” is pleased to announce that Doug Drysdale, Cybin’s Chief Ex
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.